Dianthus Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
/ 
Frequently asked questions
To buy Dianthus Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Dianthus Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Dianthus Therapeutics Inc. is DNTH:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Dianthus Therapeutics Inc. has its primary listing on NASDAQ. You can trade Dianthus Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Dianthus Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Dianthus Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Dianthus Therapeutics Inc..